Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases

Source link : https://www.yourblogdomain.com/2024/07/28/sirnaomics-announces-completion-of-ind-enabling-studies-of-safety-and-efficacy-for-stp125g-with-nhp-models-targeting-apoc3-for-treatment-of-cardiovascular-diseases/

Source link : https://news7.asia/news/sirnaomics-announces-completion-of-ind-enabling-studies-of-safety-and-efficacy-for-stp125g-with-nhp-models-targeting-apoc3-for-treatment-of-cardiovascular-diseases/ HONG KONG, GERMANTOWN, MD & SUZHOU BIOBAY, CHINA, July 23, 2024 – (ACN Newswire) – Sirnaomics Ltd. (HKG: 2257), ‘Sirnaomics’ or the “Company”, together with subsidiaries the “Group”, a leading biopharmaceutical company engaging in the discovery and development of advanced RNAi therapeutics, announced today that it has completed IND-enabling studies for […]

—-

Author : yourblogdomain

Publish date : 2024-07-28 22:46:10

Copyright for syndicated content belongs to the linked Source.